Cargando…

The Prevalence of unexpected antibodies in Saudi's plasma prior blood transfusion and their association with clinical conditions: A cross-sectional study

Unexpected antibodies, also called irregular antibodies, are not known to exist in a person's serum before testing. This research aims to assess the prevalence of unexpected antibodies and their correlation with several clinical conditions. This cross-sectional prospective study, undertaken fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Waggiallah, Hisham Ali, Alenzi, Faris Q., Bin Shaya, Abdulkarim S., Hattan Hattan, Ahmed, Mohammed Elmosaad, Yousif, Alenazi, Maher M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324960/
https://www.ncbi.nlm.nih.gov/pubmed/34354457
http://dx.doi.org/10.1016/j.sjbs.2021.04.083
_version_ 1783731470689370112
author Waggiallah, Hisham Ali
Alenzi, Faris Q.
Bin Shaya, Abdulkarim S.
Hattan Hattan, Ahmed
Mohammed Elmosaad, Yousif
Alenazi, Maher M.
author_facet Waggiallah, Hisham Ali
Alenzi, Faris Q.
Bin Shaya, Abdulkarim S.
Hattan Hattan, Ahmed
Mohammed Elmosaad, Yousif
Alenazi, Maher M.
author_sort Waggiallah, Hisham Ali
collection PubMed
description Unexpected antibodies, also called irregular antibodies, are not known to exist in a person's serum before testing. This research aims to assess the prevalence of unexpected antibodies and their correlation with several clinical conditions. This cross-sectional prospective study, undertaken from June 2019 to June 2020, included ABO, Rh grouping, cross-matching, and antibody screening. Antibody identification was performed only on patients who tested positive in the screening test. From a total of 9764 participants who were screened for unexpected antibodies, 107 (1.1%) tested positive. The Rh blood group system antibodies were the most frequent, particularly anti-D. There was also a significant correlation between the unexpected antibodies and history of transfusion, pregnancy, and autoimmune diseases as P ≤ 0.05. The most prominent unexpected antibodies in the study belong to the Rh system (Anti-D). Moreover, as a result of the strong correlation between the unexpected antibodies as well as the history of transfusion, pregnancy, and autoimmune diseases, the highest safety criteria must be followed during the transfusion of blood to patients with these clinical conditions.
format Online
Article
Text
id pubmed-8324960
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83249602021-08-04 The Prevalence of unexpected antibodies in Saudi's plasma prior blood transfusion and their association with clinical conditions: A cross-sectional study Waggiallah, Hisham Ali Alenzi, Faris Q. Bin Shaya, Abdulkarim S. Hattan Hattan, Ahmed Mohammed Elmosaad, Yousif Alenazi, Maher M. Saudi J Biol Sci Original Article Unexpected antibodies, also called irregular antibodies, are not known to exist in a person's serum before testing. This research aims to assess the prevalence of unexpected antibodies and their correlation with several clinical conditions. This cross-sectional prospective study, undertaken from June 2019 to June 2020, included ABO, Rh grouping, cross-matching, and antibody screening. Antibody identification was performed only on patients who tested positive in the screening test. From a total of 9764 participants who were screened for unexpected antibodies, 107 (1.1%) tested positive. The Rh blood group system antibodies were the most frequent, particularly anti-D. There was also a significant correlation between the unexpected antibodies and history of transfusion, pregnancy, and autoimmune diseases as P ≤ 0.05. The most prominent unexpected antibodies in the study belong to the Rh system (Anti-D). Moreover, as a result of the strong correlation between the unexpected antibodies as well as the history of transfusion, pregnancy, and autoimmune diseases, the highest safety criteria must be followed during the transfusion of blood to patients with these clinical conditions. Elsevier 2021-08 2021-05-07 /pmc/articles/PMC8324960/ /pubmed/34354457 http://dx.doi.org/10.1016/j.sjbs.2021.04.083 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Article
Waggiallah, Hisham Ali
Alenzi, Faris Q.
Bin Shaya, Abdulkarim S.
Hattan Hattan, Ahmed
Mohammed Elmosaad, Yousif
Alenazi, Maher M.
The Prevalence of unexpected antibodies in Saudi's plasma prior blood transfusion and their association with clinical conditions: A cross-sectional study
title The Prevalence of unexpected antibodies in Saudi's plasma prior blood transfusion and their association with clinical conditions: A cross-sectional study
title_full The Prevalence of unexpected antibodies in Saudi's plasma prior blood transfusion and their association with clinical conditions: A cross-sectional study
title_fullStr The Prevalence of unexpected antibodies in Saudi's plasma prior blood transfusion and their association with clinical conditions: A cross-sectional study
title_full_unstemmed The Prevalence of unexpected antibodies in Saudi's plasma prior blood transfusion and their association with clinical conditions: A cross-sectional study
title_short The Prevalence of unexpected antibodies in Saudi's plasma prior blood transfusion and their association with clinical conditions: A cross-sectional study
title_sort prevalence of unexpected antibodies in saudi's plasma prior blood transfusion and their association with clinical conditions: a cross-sectional study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324960/
https://www.ncbi.nlm.nih.gov/pubmed/34354457
http://dx.doi.org/10.1016/j.sjbs.2021.04.083
work_keys_str_mv AT waggiallahhishamali theprevalenceofunexpectedantibodiesinsaudisplasmapriorbloodtransfusionandtheirassociationwithclinicalconditionsacrosssectionalstudy
AT alenzifarisq theprevalenceofunexpectedantibodiesinsaudisplasmapriorbloodtransfusionandtheirassociationwithclinicalconditionsacrosssectionalstudy
AT binshayaabdulkarims theprevalenceofunexpectedantibodiesinsaudisplasmapriorbloodtransfusionandtheirassociationwithclinicalconditionsacrosssectionalstudy
AT hattanhattanahmed theprevalenceofunexpectedantibodiesinsaudisplasmapriorbloodtransfusionandtheirassociationwithclinicalconditionsacrosssectionalstudy
AT mohammedelmosaadyousif theprevalenceofunexpectedantibodiesinsaudisplasmapriorbloodtransfusionandtheirassociationwithclinicalconditionsacrosssectionalstudy
AT alenazimaherm theprevalenceofunexpectedantibodiesinsaudisplasmapriorbloodtransfusionandtheirassociationwithclinicalconditionsacrosssectionalstudy
AT waggiallahhishamali prevalenceofunexpectedantibodiesinsaudisplasmapriorbloodtransfusionandtheirassociationwithclinicalconditionsacrosssectionalstudy
AT alenzifarisq prevalenceofunexpectedantibodiesinsaudisplasmapriorbloodtransfusionandtheirassociationwithclinicalconditionsacrosssectionalstudy
AT binshayaabdulkarims prevalenceofunexpectedantibodiesinsaudisplasmapriorbloodtransfusionandtheirassociationwithclinicalconditionsacrosssectionalstudy
AT hattanhattanahmed prevalenceofunexpectedantibodiesinsaudisplasmapriorbloodtransfusionandtheirassociationwithclinicalconditionsacrosssectionalstudy
AT mohammedelmosaadyousif prevalenceofunexpectedantibodiesinsaudisplasmapriorbloodtransfusionandtheirassociationwithclinicalconditionsacrosssectionalstudy
AT alenazimaherm prevalenceofunexpectedantibodiesinsaudisplasmapriorbloodtransfusionandtheirassociationwithclinicalconditionsacrosssectionalstudy